SURG-21. Revisiting the Relationship Between Tumor-to-CST Distance and Subcortical MEP Thresholds in Brain Tumor Surgery

Abstract BACKGROUND The relationship between tumor-to-corticospinal tract (CST) distance and the subcortical motor evoked potential (scMEP) threshold remains unclear. This study examines how contrast-enhancement charecteristics influence this correlation. METHODS We retrospectively analyzed preoperative imaging and intraoperative electrophysiological data from 323 patients who underwent resection of intra-axial tumors adjacent to the CST. We recorded the shortest distance from the tumor margin to the CST (as defined by DTI-based tractography) and the lowest stimulation current required to elicit an scMEP. To ensure the lowest threshold corresponded the minimal tumor-to-CST distance, only patient underwent gross total resection were included. Correlation between tumor-to-CST distance and scMEP threshold were analyzed, stratified by contrast enhancement status. RESULTS Of the 203 patients meeting inclusion criteria, 158 had contrast-enhancing tumors. The mean preoperative tumor-to-CST distance was 9 ± 7.4 mm (range: 0–20 mm) for enhancing tumors and 7.2 ± 5.4 mm (range: 0.9–20 mm) for non-enhancing tumors. The mean lowest scMEP threshold was 7.9 ± 4.7 mA (range: 1–25 mA) for enhancing tumors and 6.5 ± 4.5 mA (range: 1–20 mA) for non-enhancing tumors. A strong correlation was observed between tumor-to-CST distance and scMEP threshold in non-enhancing tumors (r = 0.73; 95% CI: 0.54–0.85; P <.0001), whereas the correlation was weaker in enhancing tumors (r = 0.37; 95% CI: 0.21–0.51; P <.0001). CONCLUSIONS In non-enhancing tumors, preoperative tumor-to-CST distance reliably predicts the minimal current required to elicit an scMEP. However, in contrast-enhancing tumors, intraoperative scMEP mapping offers superior functional guidance, underscoring its critical role in surgical planning and decision-making.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-11-01
DOI
https://doi.org/10.1093/neuonc/noaf201.1578
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SURG-21. Revisiting the Relationship Between Tumor-to-CST Distance and Subcortical MEP Thresholds in Brain Tumor Surgery

Neomi Singer, Segev Gabay, Amir Hadanny, Tal Shahar et al.
Neuro-Oncology
Glioma Diagnosis and Treatment
article

SURG-21. Revisiting the Relationship Between Tumor-to-CST Distance and Subcortical MEP Thresholds in Brain Tumor Surgery

Neomi Singer, Segev Gabay, Amir Hadanny, Tal Shahar, Ido Strauss, Uri Rozovski, Akiva Korn, Zvi Ram, Assaf Berger, Neomi Kahana Levi, Guy Gurevits, Rik Demaerel, Claudia Schlimper
article en

Abstract

Abstract BACKGROUND The relationship between tumor-to-corticospinal tract (CST) distance and the subcortical motor evoked potential (scMEP) threshold remains unclear. This study examines how contrast-enhancement charecteristics influence this correlation. METHODS We retrospectively analyzed preoperative imaging and intraoperative electrophysiological data from 323 patients who underwent resection of intra-axial tumors adjacent to the CST. We recorded the shortest distance from the tumor margin to the CST (as defined by DTI-based tractography) and the lowest stimulation current required to elicit an scMEP. To ensure the lowest threshold corresponded the minimal tumor-to-CST distance, only patient underwent gross total resection were included. Correlation between tumor-to-CST distance and scMEP threshold were analyzed, stratified by contrast enhancement status. RESULTS Of the 203 patients meeting inclusion criteria, 158 had contrast-enhancing tumors. The mean preoperative tumor-to-CST distance was 9 ± 7.4 mm (range: 0–20 mm) for enhancing tumors and 7.2 ± 5.4 mm (range: 0.9–20 mm) for non-enhancing tumors. The mean lowest scMEP threshold was 7.9 ± 4.7 mA (range: 1–25 mA) for enhancing tumors and 6.5 ± 4.5 mA (range: 1–20 mA) for non-enhancing tumors. A strong correlation was observed between tumor-to-CST distance and scMEP threshold in non-enhancing tumors (r = 0.73; 95% CI: 0.54–0.85; P <.0001), whereas the correlation was weaker in enhancing tumors (r = 0.37; 95% CI: 0.21–0.51; P <.0001). CONCLUSIONS In non-enhancing tumors, preoperative tumor-to-CST distance reliably predicts the minimal current required to elicit an scMEP. However, in contrast-enhancing tumors, intraoperative scMEP mapping offers superior functional guidance, underscoring its critical role in surgical planning and decision-making.

Neuro-OncologyVol. 27(Supplement_5)
Kaleida Health (US), Tel Aviv University (IL), Tel Aviv Sourasky Medical Center (IL), AZ Groeninge (BE), Rabin Medical Center (IL), Kliniken der Stadt Köln (DE), LVR-Klinik Köln (DE)
Openalex Percentile: Top 52%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.